Ercem Atillasoy
General Counsel chez Viracyte, Inc.
Fortune : 99 186 $ au 31/03/2024
Profil
Ercem Atillasoy is currently the Chief Regulatory & Safety Officer at Viracyte, Inc. Prior to this, he held the position of Vice President at Merck Research Laboratories Massachusetts LLC.
From 2020 to 2022, he served as the Chief Regulatory & Safety Officer at AlloVir, Inc. Dr. Atillasoy completed his undergraduate degree at City University of New York and also studied at Yale School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ALLOVIR INC
0,12% | 21/10/2022 | 131 372 ( 0,12% ) | 99 186 $ | 31/03/2024 |
Postes actifs de Ercem Atillasoy
| Sociétés | Poste | Début |
|---|---|---|
Viracyte, Inc.
 Viracyte, Inc. BiotechnologyHealth Technology Viracyte, Inc. engages in biotechnology industry group. The company is headquartered in New Brighton, MN. | General Counsel | - |
Anciens postes connus de Ercem Atillasoy
| Sociétés | Poste | Fin |
|---|---|---|
| ALLOVIR, INC. | Corporate Officer/Principal | 01/10/2022 |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The private company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Corporate Officer/Principal | - |
Formation de Ercem Atillasoy
| City University of New York | Undergraduate Degree |
| Yale School of Medicine | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ALLOVIR, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The private company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Health Technology |
Viracyte, Inc.
Viracyte, Inc. BiotechnologyHealth Technology Viracyte, Inc. engages in biotechnology industry group. The company is headquartered in New Brighton, MN. | Health Technology |
